An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
